Design and synthesis of potent in vivo antagonists of oxytocin.

@article{Bakowski1980DesignAS,
  title={Design and synthesis of potent in vivo antagonists of oxytocin.},
  author={K. Bańkowski and M. Manning and J. Seto and J. Haldar and W. H. Sawyer},
  journal={International journal of peptide and protein research},
  year={1980},
  volume={16 5},
  pages={
          382-91
        }
}
  • K. Bańkowski, M. Manning, +2 authors W. H. Sawyer
  • Published 1980
  • Chemistry, Medicine
  • International journal of peptide and protein research
  • We have previously shown that the substitution of 8-ornithine and 2-O-methyltyrosine alone and in combination in [1-deaminopenicillamine] oxytocin (dPOT) brought about enhancements in antagonistic potencies to responses to oxytocin in vivo. To explore the effects of these substitutions in analogs of dPOT containing larger alkyl substitutents on the beta carbon at position 1 and on the tyrosine residue at position two, the following six analogs were synthesized: [1-(beta-mercapto-beta, beta… CONTINUE READING
    109 Citations
    Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressin.
    • 23
    Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressin.
    • 27
    Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban
    • M. Manning, L. Cheng, +6 authors C. Barberis
    • Chemistry, Medicine
    • Journal of peptide science : an official publication of the European Peptide Society
    • 2005
    • 22
    Synthesis of oxytocin antagonists containing conformationally constrained amino acids in position 2.
    • 17
    125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand.
    • 223

    References

    SHOWING 1-10 OF 29 REFERENCES
    Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.
    • 25
    [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    • 19
    Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
    • 3
    A highly potent analogue of oxytocin, desamino-oxytocin.
    • 142